New cancer suppressor gene for colorectal adenocarcinoma: Filamin a

World Journal of Gastroenterology

Volumn 21, Issue 7, 2015, Pages 2199-2205

  Tian, Zi Qiang ^a   Shi, Jian Wei ^b   Wang, Xiao Ran ^a   Li, Zhong ^b   Wang, Gui Ying ^a  

^a HEBEI MEDICAL UNIVERSITY   (China)

^b HEBEI UNIVERSITY   (China)

Author keywords

Colorectal carcinoma; Filamin A; Immunohistochemistry; Reverse transcription polymerase chain reaction; Western blot

Indexed keywords

FILAMIN A; TUMOR MARKER; FILAMIN; FLNA PROTEIN, HUMAN;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER LOCALIZATION; CANCER PROGNOSIS; CANCER SIZE; CANCER TISSUE; CLINICAL ARTICLE; COLORECTAL CARCINOMA; FEMALE; GENE EXPRESSION; HUMAN; IMMUNOHISTOCHEMISTRY; LIVER METASTASIS; LYMPH NODE METASTASIS; MALE; PROTEIN ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR SUPPRESSOR GENE; WESTERN BLOTTING; ADENOCARCINOMA; CHEMISTRY; CHI SQUARE DISTRIBUTION; COLON RESECTION; COLONIC NEOPLASMS; DOWN REGULATION; GENETICS; KAPLAN MEIER METHOD; LIVER TUMOR; MIDDLE AGED; MORTALITY; MULTIVARIATE ANALYSIS; PATHOLOGY; PREDICTIVE VALUE; PROPORTIONAL HAZARDS MODEL; RISK FACTOR; SECONDARY; TREATMENT OUTCOME; TUMOR INVASION; TUMOR VOLUME;

ADENOCARCINOMA; BIOMARKERS, TUMOR; BLOTTING, WESTERN; CHI-SQUARE DISTRIBUTION; COLECTOMY; COLONIC NEOPLASMS; DOWN-REGULATION; FEMALE; FILAMINS; GENES, TUMOR SUPPRESSOR; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIER ESTIMATE; LIVER NEOPLASMS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM INVASIVENESS; PREDICTIVE VALUE OF TESTS; PROPORTIONAL HAZARDS MODELS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RISK FACTORS; TREATMENT OUTCOME; TUMOR BURDEN;

EID: 84922758126     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v21.i7.2199     Document Type: Article

References (26)

1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T, Thun MJ. Cancer statistics, 2008. CA Cancer J Clin 2008; 58: 71-96 [PMID: 18287387 DOI: 10.3322/CA.2007.0010]
2. Kolahi KS, Mofrad MR. Molecular mechanics of filamin's rod domain. Biophys J 2008; 94: 1075-1083 [PMID: 17921200 DOI: 10.1529/biophysj.107.118802]
3. Stevenson RP, Veltman D, Machesky LM. Actin-bundling proteins in cancer progression at a glance. J Cell Sci 2012; 125: 1073-1079 [PMID: 22492983 DOI: 10.1242/jcs.093799]
4. Shi JW, Wang GY, Zhang HB, Yu YM, Wang XL, Yang HC, Wang SJ. Specific Expression of FLNa in Colorectal Adenocarcinoma. Zhongguo Zhongliu Linchuang 2010; 37: 1342-1343
5. Shi JW, Liu HY, Wang GY, Yu YM, Wang XL, Yang HC, Wang SJ. Expression of FLNa in Colorectal Adenocarcinoma its clinical significance. Zhongguo Laonianxue Zazhi 2010; 13: 009
6. Shi JW, Yu YM, Wang SJ, Wang XL, Zhang J, Wang GY. Expressiom of Filamin A and Matrix Metalloproteinase-9 in Colorectal Adenocarcinoma and Their Significance. Zhongliu 2011; 30: 768-773
7. Burgess DJ. Gene expression: colorectal cancer classifications. Nat Rev Cancer 2013; 13: 380-381 [PMID: 23640209 DOI: 10.1038/nrc3529]
8. Sadanandam A, Lyssiotis CA, Homicsko K, Collisson EA, Gibb WJ, Wullschleger S, Ostos LC, Lannon WA, Grotzinger C, Del Rio M, Lhermitte B, Olshen AB, Wiedenmann B, Cantley LC, Gray JW, Hanahan D. A colorectal cancer classification system that associates cellular phenotype and responses to therapy. Nat Med 2013; 19: 619-625 [PMID: 23584089 DOI: 10.1038/nm.3175]
9. Nakamura F, Osborn TM, Hartemink CA, Hartwig JH, Stossel TP. Structural basis of filamin A functions. J Cell Biol 2007; 179: 1011-1025 [PMID: 18056414 DOI: 10.1083/jcb.200707073]
10. Robertson SP, Twigg SR, Sutherland-Smith AJ, Biancalana V, Gorlin RJ, Horn D, Kenwrick SJ, Kim CA, Morava E, Newbury-Ecob R, Orstavik KH, Quarrell OW, Schwartz CE, Shears DJ, Suri M, Kendrick-Jones J, Wilkie AO. Localized mutations in the gene encoding the cytoskeletal protein filamin A cause diverse malformations in humans. Nat Genet 2003; 33: 487-491 [PMID: 12612583 DOI: 10.1038/ng1119]
11. Kim H, Sengupta A, Glogauer M, McCulloch CA. Filamin A regulates cell spreading and survival via beta1 integrins. Exp Cell Res 2008; 314: 834-846 [PMID: 18177638 DOI: 10.1016/j.yexcr.2007.11.022]
12. Shi JW, Wang SJ, Wang GY. Research Advance on Role of Filamin A in Tumor Progression. Zhongliu Fangzhiyanjiu 2010; 8: 029
13. Shi JW, Wang GY. Research Advance on Role of Filamin A in regulating development of organs. Aibian Jibian Tubian 2012; 24: 78-80
14. Shi JW, Yu YM, Wang SJ, Yang S, Kong FL, Zhang J, Wang GY. Inhibitory effect of filamin A on invasion and metastasis of human colon carcinoma cell line SW480 in vitro. Jichuyixue yu Linchuang 2011; 31: 1000-1005
15. Shi JW, Yu YM, Wang SJ, Wang XL, Wang GY. Inhibitory effect of filamin A on tumor formation activity of human colon carcinoma SW480 cells in nude mice. Zhongliu 2011; 31: 701-706
16. Kwon M, Lee SJ, Reddy S, Rybak Y, Adem A, Libutti SK. Downregulation of Filamin A interacting protein 1-like Is associated with promoter methylation and an invasive phenotype in breast, colon, lung and pancreatic cancers [corrected]. PLoS One 2013; 8: e82620 [PMID: 24340050 DOI: 10.1371/journal.pone.0082620]
17. Vial D, McKeown-Longo PJ. Epidermal growth factor (EGF) regulates α5β1 integrin activation state in human cancer cell lines through the p90RSK-dependent phosphorylation of filamin A. J Biol Chem 2012; 287: 40371-40380 [PMID: 23007402 DOI: 10.1074/jbc.M112.389577]
18. Zhu TN, He HJ, Kole S, D'Souza T, Agarwal R, Morin PJ, Bernier M. Filamin A-mediated down-regulation of the exchange factor Ras-GRF1 correlates with decreased matrix metalloproteinase-9 expression in human melanoma cells. J Biol Chem 2007; 282: 14816-14826 [PMID: 17389601 DOI: 10.1074/jbc.M611430200]
19. Fiori JL, Zhu TN, O'Connell MP, Hoek KS, Indig FE, Frank BP, Morris C, Kole S, Hasskamp J, Elias G, Weeraratna AT, Bernier M. Filamin A modulates kinase activation and intracellular trafficking of epidermal growth factor receptors in human melanoma cells. Endocrinology 2009; 150: 2551-2560 [PMID: 19213840 DOI: 10.1210/en.2008-1344]
20. Sasaki A, Masuda Y, Ohta Y, Ikeda K, Watanabe K. Filamin associates with Smads and regulates transforming growth factor-beta signaling. J Biol Chem 2001; 276: 17871-17877 [PMID: 11278410]
21. Feng Y, Walsh CA. The many faces of filamin: a versatile molecular scaffold for cell motility and signalling. Nat Cell Biol 2004; 6: 1034-1038 [PMID: 15516996 DOI: 10.1038/ncb1104-1034]
22. Sanz-García E, Elez E, Macarulla T, Dienstmann R, Salazar R, & Tabernero J. Prognosis and Therapeutic Implications for Emerging Colorectal Cancer Subtypes. Current Colorectal Cancer Reports 2014: 1-7
23. Kim HJ, Kang UB, Lee H, Jung JH, Lee ST, Yu MH, Kim H, Lee C. Profiling of differentially expressed proteins in stage IV colorectal cancers with good and poor outcomes. J Proteomics 2012; 75: 2983-2997 [PMID: 22178445 DOI: 10.1016/j.jprot.2011.12.002]
24. Mettu NB, Hurwitz H, Hsu DS. Use of molecular biomarkers to inform adjuvant therapy for colon cancer. Oncology (Williston Park) 2013; 27: 746-754 [PMID: 24133820]
25. Ang CS, Nice EC. Targeted in-gel MRM: a hypothesis driven approach for colorectal cancer biomarker discovery in human feces. J Proteome Res 2010; 9: 4346-4355 [PMID: 20684568 DOI: 10.1021/pr100509e]
26. Buckhaults P, Kinzler KW, Vogelstein B. Methods for detection of colorectal cancer: U.S.. Patent: 8029764, 2011